Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00594347 | Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar | PHASE3 | COMPLETED | 339 | — | — | Nov 1, 2007 | Apr 1, 2009 | Jun 18, 2015 | 2 | Thailand |
| Arm | Type | Description |
|---|---|---|
| Group A | EXPERIMENTAL | Pneumo 23 |
| Group B | ACTIVE_COMPARATOR | Prevnar |
| Name | Type | Description |
|---|---|---|
| Pneumo 23 | BIOLOGICAL | Vaccine (Pneumo 23) |
| Prevnar | BIOLOGICAL | Vaccine (Prevnar) |
Inclusion Criteria: * Aged 12 to 18 months on the day of inclusion * Informed consent form signed by the parent/legally acceptable representative and by an independent witness if requested by local Ethics Committee regulation or/and if the parent/legally acceptable representative is illiterate * Ch...